|
ZNF286A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.910600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.709000E-01 |
| Normal-vs-Stage2 |
8.876000E-01 |
| Normal-vs-Stage3 |
2.784800E-01 |
| Normal-vs-Stage4 |
7.549800E-01 |
| Stage1-vs-Stage2 |
5.580600E-01 |
| Stage1-vs-Stage3 |
5.451700E-02 |
| Stage1-vs-Stage4 |
4.019200E-01 |
| Stage2-vs-Stage3 |
5.490200E-01 |
| Stage2-vs-Stage4 |
8.728200E-01 |
| Stage3-vs-Stage4 |
7.466600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.809600E-01 |
| Normal-vs-AfricanAmerican |
3.877600E-01 |
| Normal-vs-Asian |
7.348000E-01 |
| Caucasian-vs-AfricanAmerican |
2.479200E-01 |
| Caucasian-vs-Asian |
7.712400E-01 |
| AfricanAmerican-vs-Asian |
9.050600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.231800E-01 |
| Normal-vs-Female |
2.263500E-02 |
| Male-vs-Female |
1.062390E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.866200E-01 |
| Normal-vs-Extreme_Weight |
3.833600E-02 |
| Normal-vs-Obese |
1.959990E-01 |
| Normal-vs-Extreme_Obese |
2.978400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.402400E-01 |
| Normal_Weight-vs-Obese |
2.166400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.918200E-01 |
| Extreme_Weight-vs-Obese |
4.658500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.260200E-01 |
| Obese-vs-Extreme_Obese |
1.610240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.794760E-01 |
| Normal-vs-Age(41-60Yrs) |
1.118980E-01 |
| Normal-vs-Age(61-80Yrs) |
1.712610E-01 |
| Normal-vs-Age(81-100Yrs) |
6.460300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.964600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.730400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.287940E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.496800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.183520E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.919810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.691600E-01 |
| Normal-VS-Type2 PRCC |
4.581100E-03 |
| Normal-VS-KIRP CIMP |
8.369600E-02 |
| Normal-VS-Unclassified PRCC |
1.888420E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.211000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.162310E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.495600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.743760E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.321700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.351000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.007800E-02 |
| Normal-vs-N1 |
3.597700E-02 |
| Normal-vs-N2 |
1.112820E-01 |
| N0-vs-N1 |
3.375300E-03 |
| N0-vs-N2 |
6.645200E-01 |
| N1-vs-N2 |
1.070960E-01 |
|
|
